The regenerative capacity of the zebrafish heart is dependent on TGFβ signaling by Chablais, Fabian & Jaźwińska, Anna
INTRODUCTION
In adult mammals, a heart infarction heals by deposition of a
permanent collagenous scar instead of restoration of functional
cardiac tissue (Laflamme and Murry, 2011). By contrast, an
impressive regenerative capacity has been demonstrated in the
heart of zebrafish and newts (Ausoni and Sartore, 2009; Major and
Poss, 2007; Singh et al., 2010). In contrast to mammals, these
animals sustain a robust proliferative competence of
cardiomyocytes in adult life, which provides a source of a new
myocardium.
The zebrafish serves as a particularly useful model system with
which to study the regenerative response to myocardial damage, as
shown by experiments involving resection of the ventricular apex,
cryoinjury and genetic cardiomyocyte depletion (Chablais et al.,
2011; Gonzalez-Rosa et al., 2011; Schnabel et al., 2011; Wang et
al., 2011). Cell lineage-tracing analyses have demonstrated that
complete repair of the amputated myocardial apex predominantly
involves cell cycle re-entry of existing cardiomyocytes, as opposed
to recruitment of epicardial stem cells (Jopling et al., 2010; Kikuchi
et al., 2011a; Kikuchi et al., 2010). Despite progress in the last
decade, little is known about the molecular factors that control
heart restoration. Studies applying transgenesis have revealed a
requirement of the FGF and retinoic acid (RA) signaling pathways
in epicardial activation and in stimulation of cardiomyocyte
proliferation (Kikuchi et al., 2011b; Lepilina et al., 2006). Using a
small-molecule inhibition approach it has been shown that PDGF
signaling is required for epicardial function and blood vessel
formation in regenerating zebrafish hearts (Kim et al., 2010; Lien
et al., 2006). These findings support the hypothesis that organ
regeneration is regulated by secreted factors that mediate
communication between adjacent cardiac and non-cardiac tissues.
The advantage of the zebrafish model system in regenerative
biology has recently been reinforced by establishing a myocardial
infarction model using a cryoinjury procedure, which involves
direct freezing of the ventricular wall (Chablais et al., 2011;
Gonzalez-Rosa et al., 2011; Schnabel et al., 2011). Compared with
ventricular resection or genetic cardiomyocyte depletion, this
procedure is of particular value because it mimics different
physiological responses observed in mammals, including cell death
and scarring. After reparative events, zebrafish infarcted hearts
progress to a unique regenerative phase. The initially deposited scar
tissue becomes completely replaced with new cardiac muscle
within 2 months following cryoinjury. Remarkably, proliferation of
cardiomyocytes is triggered simultaneously with the scar
deposition. The progressive cardiomyocyte propagation into the
injury area is accompanied by local regression of fibrotic tissue.
Thus, cardiac regeneration involves different responses of cardiac
and non-cardiac cell types, which have to be spatially and
temporally orchestrated to achieve a balance between the reparative
and regenerative processes. Little is known about the molecules
that coordinate the function of the various cellular components to
achieve this successful regeneration.
In the present study, we identified that a molecular link between
the reparative and regenerative processes after cryoinjury-induced
myocardial infarction is achieved through Smad3-dependent
TGF/Activin signaling. We first determined the involvement of
the related TGF and Activin- (Inhibin ) ligands using
expression analysis at the transcript and protein levels. Next, we
visualized the spatiotemporal dynamics of pathway activation
during heart regeneration using immunostaining of a direct
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SUMMARY
Mammals respond to a myocardial infarction by irreversible scar formation. By contrast, zebrafish are able to resolve the scar and
to regenerate functional cardiac muscle. It is not known how opposing cellular responses of fibrosis and new myocardium
formation are spatially and temporally coordinated during heart regeneration in zebrafish. Here, we report that the balance
between the reparative and regenerative processes is achieved through Smad3-dependent TGF signaling. The type I receptor
alk5b (tgfbr1b) is expressed in both fibrotic and cardiac cells of the injured heart. TGF ligands are locally induced following
cryoinjury and activate the signaling pathway both in the infarct area and in cardiomyocytes in the vicinity of the trauma zone.
Inhibition of the relevant type I receptors with the specific chemical inhibitor SB431542 qualitatively altered the infarct tissue and
completely abolished heart regeneration. We show that transient scar formation is an essential step to maintain robustness of the
damaged ventricular wall prior to cardiomyocyte replacement. Taking advantage of the reversible action of the inhibitor, we
dissected the multifunctional role of TGF signaling into three crucial processes: collagen-rich scar deposition, Tenascin C-
associated tissue remodeling at the infarct-myocardium interface, and cardiomyocyte proliferation. Thus, TGF signaling
orchestrates the beneficial interplay between scar-based repair and cardiomyocyte-based regeneration to achieve complete heart
regeneration.
KEY WORDS: Cryoinjury, Heart regeneration, TGF, Zebrafish
The regenerative capacity of the zebrafish heart is
dependent on TGF signaling
Fabian Chablais* and Anna Jaz´win´ska*,‡


Published in 'HYHORSPHQW
which should be cited to refer to this work.
ht
tp
://
do
c.
re
ro
.c
h
downstream signal transducer, phospho-Smad3. To determine the
role of TGF/Activin signaling, we blocked the relevant type I
receptor with the previously characterized specific inhibitor
SB431542. Inhibition of TGF/Activin signaling suppressed
phosphorylation of Smad3 and impaired heart regeneration,
resulting in ventricular deformation. The reversible action of the
inhibitor was beneficial in dissecting the effects of TGF signaling
on several successive cellular processes. The temporal inhibition
of TGF/Activin signaling during the subacute phase revealed an
unexpected role of the transient scar in supporting the mechanical
properties of the damaged ventricle. We identified several
extracellular regulators of tissue organization and remodeling,
represented by Collagen, Fibronectin and Tenascin C, as targets of
TGF/Activin signaling. Furthermore, continuous and short-term
inhibition of the pathway demonstrated the stimulatory role of
TGF/Activins for cardiomyocyte proliferation, which is a key
mechanism of new myocardium formation. Our study provides
evidence that TGF signaling coordinates a wide spectrum of
subsequent cellular steps that are required for efficient heart
regeneration in zebrafish.
MATERIALS AND METHODS
Animal procedures
The following zebrafish strains were used: wild-type AB (Oregon),
cmlc2::DsRed2-Nuc (Rottbauer et al., 2002), flk1::EGFP (Lawson and
Weinstein, 2002) and hsp70:dn-fgfr1 (Lepilina et al., 2006). Fish at 6-18
months of age were anesthetized in 0.1% tricaine (Sigma-Aldrich) and
cryoinjury was performed as previously described (Chablais et al., 2011).
Ventricular apex resection was performed as described (Poss et al., 2002).
Animals were allowed to regenerate for various times at 26.5°C. The
Alk5/4 inhibitor SB431542 (Tocris) was used as previously described
(Jazwinska et al., 2007). The control fish were in water with 0.1% DMSO.
For BrdU incorporation analysis, the fish were incubated for 24 hours in
water containing 50 g/ml BrdU (Sigma-Aldrich). hsp70:dn-fgfr1 fish
received daily heat shocks by raising the water temperature to 37°C for 1
hour. The experimental research on animals was approved by the cantonal
veterinary office of Fribourg.
Histological techniques and immunohistochemistry
Acid Fuchsin Orange-G (AFOG) staining was performed as described
previously (Poss et al., 2002). For immunohistochemistry, the primary
antibodies used were: rabbit anti-TGF receptor I at 1:50 (AnaSpec,
53895), mouse anti-Tropomyosin at 1:100 [developed by Jung-Ching Lin,
obtained from the Developmental Studies Hybridoma Bank (DSHB),
CH1], mouse anti-GFP at 1:100 (Roche, 11814460001), rabbit anti-Raldh2
at 1:400 (GeneTex, GTX124302), rabbit anti-Tenascin C at 1:500
(USBiological, T2550-23), mouse anti-Vimentin at 1:70 (developed by
Alvarez-Buylla, obtained from DSHB, 40E-C), rabbit anti--SMA at 1:200
(GeneTex, GTX1000345), rabbit anti-Mcm5 at 1:5000 (kindly provided by
Soojin Ryu, MPI for Medical Research, Heidelberg, Germany), rabbit anti-
Fibronectin at 1:400 (Sigma-Aldrich, F3648), rabbit anti-phospho-Smad3
at 1:400 (Abcam, ab52903) and rat anti-BrdU at 1:100 (Abcam, ab6326).
The secondary antibodies used (at 1:500) were: goat anti-rabbit Alexa
Fluor 488, goat anti-mouse Alexa Fluor 488 (Molecular Probes), goat anti-
rabbit Cy3 or Cy5 conjugated, goat anti-mouse DyLight 549 or 649
conjugated (Jackson ImmunoResearch).
Hearts were fixed, cryosectioned at 16 m and immunostained as
previously described (Chablais et al., 2011). The specimens were analyzed
by confocal microscopy (Leica TCS-SP5). For quantification of
proliferating cardiac cells, Mcm5/DsRed2 or BrdU/DsRed2 double-
positive nuclei were normalized as the percentage of the total number of
DsRed2-positive nuclei using ImageJ 1.44p software. For quantification of
proliferating non-cardiac cells, the number of Mcm5-positive DsRed-
negative cells was normalized as the percentage of the total number of
DAPI-positive cells of the ventricle.
In situ hybridization
In situ hybridization on cryosections was performed as described (Chablais
and Jazwinska, 2010). Primers are listed in supplementary material Table
S1.
In situ hybridization combined with antibody staining
After standard in situ hybridization staining, the sections were washed in
PBS for 30 minutes and postfixed in 70% ethanol for 30 minutes. The
slides were rinsed in PBST (PBS, 0.3% Triton X-100) and incubated with
PBST plus 5% goat serum for 1 hour. The primary antibodies are listed
above. The slides were processed using the Vectastain ABC Kit (Vector
Labs) according to the manufacturer’s instructions. Secondary antibodies
(Vector Labs) were biotinylated anti-mouse (BA-2000) and biotinylated
anti-rabbit (BA-1000) diluted 1:200. The antibody staining was detected
using DAB solution (Sigma-Aldrich, D5905).
Electrocardiogram (ECG) recordings and acquisition
All ECGs were recorded in triplicate before injury and at subsequent time
points after surgery. To reduce biological variation, the same six animals
were recorded before and after injury. ECG acquisitions were performed
as previously described (Chablais et al., 2011).
RESULTS
Induction of TGF signaling in the regenerating
zebrafish heart
A class of molecular signals that are known to be injury activated
in various organs is represented by structurally related TGF and
Activin cytokines (Dobaczewski et al., 2010a; Werner and
Alzheimer, 2006). In vertebrates, several isoforms of these family
members have been identified (Massague and Gomis, 2006). We
tested the expression of Activin and TGF genes by in situ
hybridization using control hearts from sham-injured zebrafish [4
days post sham (dps)] and regenerating hearts at the onset of infarct
healing [4 days post cryoinjury (dpci)], and at 14 dpci when the
transition between scar formation and scar resorption becomes
evident. activin-A (inhbaa – Zebrafish Information Network) was
not significantly detected in control and injured hearts, whereas
activin-B (inhbb – Zebrafish Information Network) was
ubiquitously expressed only in regenerating hearts (supplementary
material Fig. S1). By contrast, three known TGF isoforms, tgfb1,
tgfb2 and tgfb3, showed specific upregulation in the post-infarct
zone of the injured hearts at 4 and 14 dpci (Fig. 1F-H and
supplementary material Fig. S2A-D). The injury area was
identified by the absence of the ventricular myosin heavy chain
(vmhc) transcript (Fig. 1E). The control hearts did express TGF
genes (Fig. 1A-D).
To further determine the expression domain of the TGF
isoforms in the infarcted hearts, we combined in situ hybridization
with antibody staining for marker proteins of different cell types in
the heart. High-resolution imaging of double-stained sections did
not reveal expression of TGF genes in the intact Tropomyosin-
positive myocardium, except for a thin layer of cardiomyocytes
abutting the infarct area (Fig. 1I and supplementary material Fig.
S2H,I). Most of the Raldh2-expressing epicardial cells and
Vimentin-expressing fibroblasts of the post-infarct appeared to be
positive for the TGF transcripts (Fig. 1J,K and supplementary
material Fig. S2J-M). By contrast, EGFP-labeled endothelial cells
did not seem to display TGF expression (Fig. 1L and
supplementary material Fig. S2N,O). We concluded that all three
TGF genes appear to be expressed in overlapping domains that
encompass several cell types, including fibroblasts and epithelial
cells of the infarct area, as well as some cardiomyocytes at the
infarct boundary.
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The TGF/Activin cytokines activate the downstream
pathway via ligand-stimulated interaction of type I and II
receptors (Massague and Gomis, 2006). We analyzed the
expression of three isoforms of type I receptors, alk5a/b and alk4
(tgfbr1a/b and acvr1b – Zebrafish Information Network), which
are specific for TGFs and Activins, respectively (Shi and
Massague, 2003). alk5a and alk4 appeared to be present in the
injured area, whereas alk5b was strongly expressed in the entire
heart (supplementary material Fig. S3). To confirm this finding,
we visualized the distribution of Alk5b protein using an antibody
against a unique amino acid sequence of this receptor.
Immunofluorescence analysis detected the presence of this
transmembrane receptor in the whole heart, including
cardiomyocytes and Vimentin-positive cells of the post-infarct
(supplementary material Figs S4 and S5). We concluded that
both cardiac and non-cardiac cells of the infarcted heart can be
responsive to TGF ligands.
The activated type I receptors transmit signaling by
phosphorylation of receptor-activated SMADs (R-SMADs), which,
in a complex with common-mediator SMADs (co-SMADs), are
translocated to the nucleus to control target gene transcription (Shi
and Massague, 2003). To determine the spatiotemporal activation of
the TGF/Activin signaling pathway during cardiac regeneration, we
visualized phospho-Smad3 (pSmad3), a specific R-SMAD for
Alk5/4 receptors. To distinguish between cardiac and non-cardiac
nuclei, we used a transgenic strain of zebrafish that expresses nuclear
DsRed2 under the control of the cardiac-specific cardiac myosin
light chain (cmlc2; myl7 – Zebrafish Information Network) promoter
(cmlc2::DsRed2-Nuc) (Rottbauer et al., 2002). To recognize healthy
myocardium, the sections were immunostained for Tropomyosin. In
hearts of uninjured fish, we did not detect significant pSmad3
immunolabeling (supplementary material Fig. S6A). However, the
hearts at 7 and 14 dpci displayed numerous pSmad3-positive nuclei
of non-cardiac cells in the post-infarct (Fig. 2A and supplementary
Fig. 1. Three TGF ligands are expressed in the infarct zone
following cryoinjury. (A-H)In situ hybridization of consecutive heart
sections with vmhc, tgfb1, tgfb2 and tgfb3 mRNA antisense probes
(blue) of control zebrafish hearts at 4 days post sham surgery (dps) (A-
D) and of cryoinjured hearts at 4 days post cryoinjury (dpci) (E-H). Red
dashed lines encircle the injured areas. (A,E)At 4 dps, vmhc expression
labels the intact ventricle. (B-D)None of the three TGF transcripts is
detected in uninjured hearts. (E)The absence of vmhc mRNA
demarcates the infarct area at 4 dpci. (F-H)At 4 dpci, tgfb1, tgfb2 and
tgfb3 are upregulated in the injured area. (I-L)Heart sections at 14 dpci
double-stained by in situ hybridization using tgfb1 probe (blue) and
immunohistochemistry using different cell type markers (brown).
Arrows indicate double-positive cells. (I)Intact Tropomyosin-labeled
myocardium does not express tgfb1, with the exception of
cardiomyocytes abutting the infarct. (J)Raldh2-positive epicardial cells
invading the injury area are co-labeled by tgfb1 staining. (K)Vimentin-
expressing fibroblasts of the infarct express tgfb1. (L)GFP expressed
under the endothelial cell promoter flk1 (kdrl – Zebrafish Information
Network) does not colocalize with tgfb1. Scale bars: 300m in A;
50m in I.
Fig. 2. Smad3-dependent TGF/Activin signaling is suppressed by
the SB431542 inhibitor (Alk5/4-i) after myocardial infarction.
(A-B) At 14 dpci, heart sections from transgenic fish expressing nuclear
DsRed2 (red) under the cmlc2 cardiomyocyte-specific promoter were
immunoassayed for Tropomyosin (TPM, blue) to visualize the intact
myocardium and phospho-Smad3 (pSmad3, green). DAPI (yellow in the
left panels) marks all the nuclei. The infarct is determined by the
absence of Tropomyosin and DsRed2 expression (encircled by dashed
lines). (A,B) Higher magnifications of the boxed areas in A,B. pSmad3-
positive cardiomyocytes are indicated with arrowheads. (A,A) Control
regenerating hearts display numerous pSmad3-positive nuclei (green) in
the injury area and in some cardiomyocytes at the infarct boundary.
Arrows (A) indicate new myocardium surrounding the post-infarct.
(B,B) Treatment with 10M Alk5/4-i severely reduces pSmad3 staining.
The injury area is larger than in the control and no invasion of
cardiomyocytes is detected. (C)Quantification of pSmad3-positive
cardiomyocytes in control and Alk5/4-i-treated hearts at 14 dpci. Error
bars indicate s.e.m.; n=9; *P<0.01, t-test. Scale bars: 300m.
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material Fig. S6B). Importantly, pSmad3 was also enhanced in a
subset of cardiomyocytes localized at the infarct boundary (Fig. 2A).
The number of pSmad3-positive nuclei declined at 30 dpci, when
cardiac regeneration was nearly complete (supplementary material
Fig. S6C,D). The visualization of pSmad3 demonstrates that the
TGF/Activin signaling pathway is activated in the fibrotic tissue
and in adjacent cardiomyocytes during heart restoration.
A small-molecule inhibitor of TGF receptor type I
blocks heart regeneration resulting in a bulging
infarct phenotype
To examine the requirement of the TGF/Activin pathway for heart
regeneration, we applied a pharmacological strategy to block type
I receptor activity. We used the low molecular weight inhibitor
SB431542 (Alk5/4-i), which specifically blocks TGF/Activin
pathway receptors and does not affect closely related receptors
from the bone morphogenetic protein (BMP) pathway or other
signal transduction pathways (Ho et al., 2006; Inman et al., 2002;
Jazwinska et al., 2007). The mechanism of this selectivity has
recently been determined by solving the crystal structure of the
mammalian TGF type I receptor kinase domain in complex with
SB431542 (Ogunjimi et al., 2012). Based on this study, we verified
that the key determinant for the selectivity of SB431542, residue
S280, as well as all the other gatekeeper residues are conserved in
Alk5/4 receptors in zebrafish (supplementary material Fig. S7).
To determine the activity of the SB431542 inhibitor in the heart
after cryoinjury, we compared pSmad3 immunostaining between
control and inhibitor-treated animals at 14 dpci. We found a
noticeable reduction of pSmad3-positive cells within the post-
infarct and the myocardium (Fig. 2B,C). We concluded that the
application of 10 M Alk5/4-i markedly suppressed TGF/Activin
signaling in the heart of adult zebrafish.
To examine the requirement of TGF/Activin signaling for heart
regeneration, we analyzed the histology of control and Alk5/4-i-
treated hearts at different time points after cryoinjury. Acid Fuchsin
Orange-G (AFOG) staining of heart sections at 4 dpci revealed a
comparable damage of ~20% of the ventricle in control and
inhibitor-treated animals with abundant fibrin accumulation (Fig.
3A,B,E,F). At 14 dpci, control hearts formed two domains of the
scar: a layer of fibrin along the outer border of the post-infarct, and
a network of collagen in the interior of the wound (Fig. 3C). By
contrast, the post-infarct of the Alk5/4-i-treated fish failed to
deposit a collagenous matrix in the lost myocardium (Fig. 3G). In
control hearts at 30 dpci, the fibrotic tissue was largely resolved
and was replaced by new muscle tissue, demonstrating substantial
cardiac regeneration (Fig. 3D). We found that such a regenerative
process was not accomplished after the inhibition of TGF/Activin
signaling (Fig. 3H). The post-infarct tissue was devoid of muscle
and remained surrounded by a layer of fibrin. Moreover, the
damaged area conspicuously bulged out from the ventricular
circumference, indicating mechanical deformation of the tissue.
To better understand this phenotype, we compared it with
another case of defective heart regeneration that occurs upon
inhibition of FGF signaling, which has been shown to be required
for heart regeneration after partial amputation (Lepilina et al.,
2006). As predicted, overexpression of a dominant-negative (dn)
Fig. 3. Inhibition of TGF/Activin signaling blocks heart regeneration resulting in the infarct bulging phenotype. Acid Fuchsin Orange-G
(AFOG) staining of heart sections visualizes healthy myocardium (orange), fibrin (red) and collagen (blue). (A-D)Control hearts, (E-H) Alk5/4-i-
treated hearts, (I-L) hearts of transgenic fish expressing heat shock-inducible dn-fgfr1. (A,E,I) Control ventricles after sham operation (4 dps) consist
of healthy myocardium. (B,F,J) At 4 dpci, similar infarcts (red) are detected in all experimental groups. (C,G,K) Hearts at 14 dpci. (C)Control hearts
contain abundant fibrillar collagen in the injury area. A layer of fibrin (red) covers the margin of the infarct. New myocardium begins to invade the
scar tissue (arrows). (G)Exposure to Alk5/4-i suppresses collagen deposition. No myocardial invasion is observed. (K)Inhibition of FGF signaling does
not impair collagenous scar formation in comparison to control. (D,H,L) Hearts at 30 dpci. (D)In control hearts, the scar was nearly completely
resolved and replaced with new muscle. (H)Alk5/4-i blocked regeneration. The infarct is surrounded by a fibrin layer but it is collagen deficient. The
injury area bulges beyond the ventricular circumference. (L)Overexpression of dn-fgfr1 blocks regeneration, resulting in a collagen-rich scar. No
geometrical deformation is associated with the lack of regeneration. Scale bar: 300m.
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form of the FGF receptor resulted in a lack of cardiac regeneration
(Fig. 3I-L). In contrast to the phenotype caused by TGF
inhibition, the post-infarct of hearts expressing dnFgfr1 contained
abundant collagen fibers, indicating excessive scarring.
Importantly, the fibrotic infarct did not protrude beyond the
ventricular circumference. The phenotypic comparison indicates
that TGF signaling is required for two processes during heart
regeneration: collagen deposition during infarct healing and
subsequent cardiac muscle regeneration.
Nonregenerated hearts after Alk5/4-i treatment
display cardiac dysfunction
To characterize the nature of the post-infarct tissue of the hearts
treated with Alk5/4-I at 30 dpci, we performed
immunofluorescence analyses using several cellular and
extracellular markers (Chablais et al., 2011). The visualization of
Tropomyosin cardiac protein confirmed the absence of myocardial
tissue within the protruding post-infarct (supplementary material
Fig. S8D,E). Instead, the injury zone was labeled by connective
tissue markers, such as the extracellular matrix (ECM) protein
Fibronectin and the intermediate filament protein Vimentin. The
infarct margin was surrounded by a layer of myofibroblasts/smooth
muscle cells that express -smooth muscle actin (-SMA). The
ECM of the post-infarct was devoid of Tenascin C, a de-adhesive
extracellular protein (supplementary material Fig. S8F). By
contrast, Tropomyosin-positive myocytes efficiently invaded the
post-infarct area in the control hearts. The residual Fibronectin,
Tenascin C, -SMA and Vimentin demarcated the position of
cryoinjury (supplementary material Fig. S8A-C). The
immunofluorescence analyses demonstrate that the inhibition of
TGF/Activin signaling impaired the replacement of connective
tissue with new cardiac tissue in the post-infarct.
To assess the physiological consequences of this phenotype, we
recorded heart conduction with an electrocardiogram (ECG). We
have previously shown that cryoinjury results in a prolonged
ventricular repolarization, displayed as QT intervals, but that the
regenerated hearts at 30 dpci recover their original electrical
properties (Chablais et al., 2011). Here, we found that the fish
treated with Alk5/4-i for 30 days after cryoinjury developed
prolonged QTc values (Fig. 4). Thus, a lack of heart regeneration
after the inhibition of TGF/Activin signaling alters cardiac
electrophysiological properties, indicating heart dysfunction.
TGF/Activin-dependent deposition of the
transient scar is essential for subsequent
regeneration
The phenotype caused by the inhibition of TGF/Activin was
associated with the absence of a collagen-containing scar and a
complete lack of cardiac regeneration (Fig. 3H). Both concomitant
defects suggest a correlation between collagenous scar formation
observed at 14 dpci and the heart restoration at 30 dpci. To
determine whether collagen deposition is beneficial for subsequent
cardiac regeneration, we designed a drug-shift experiment. After
myocardial infarction, animals were treated with Alk5/4-i during
the first 14 days to block collagenous scar formation. Then, the fish
were transferred to normal conditions for another period of 14 days
to allow regeneration to resume. At the end of the experiment at 28
dpci, heart regeneration and scarring were assayed using AFOG
staining (Fig. 5A,C).
Most of the control hearts of this experimental setting displayed
advanced regeneration with little scarring (eight hearts per group;
Fig. 5A). By contrast, the Alk5/4-i-treated animals failed to restore
the myocardial tissue (among seven animals, four hearts had a
bulging infarct, two hearts had impaired regeneration without a
significant deformation, and one heart was comparable to the
control; Fig. 5C). The post-infarct of these hearts contained
collagen fibers, especially around the infarction wall. This
demonstrates that the initially blocked deposition of collagen was
partially compensated during the 14 days in normal conditions.
Despite the resumed regeneration, the cardiac muscle failed to
Fig. 4. Electrocardiogram analyses reveal functional defects of
nonregenerated hearts after the inhibition of TGF/Activin
signaling. (A)Quantification of QTc interval, an indicator of ventricular
action potential, at three different time points after cryoinjury in control
and Alk5/4-i-treated fish. In control animals, QTc is significantly
prolonged during scar formation at 10 dpci. After regeneration at 30
dpci, the QTc value is similar to that of uninjured hearts, indicating
functional recovery. In Alk5/4-i-treated animals, the nonregenerated
hearts at 30 dpci display significantly prolonged ventricular action
potential (n6 fish, *P<0.05 compared with uninjured, t-test). Error
bars indicate s.e.m. (B,C) A representative ECG of control (B) and
Alk5/4-i-treated (C) animals shortly before the injury at 10 dpci and 30
dpci. Dashed lines indicate the beginning of the QRS waves (Q point)
and the end of the ST waves (T point) to compare the QT intervals at
different time points. The small colored arrows indicate the end of the
ST waves.
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replace the damaged tissue. Thus, the initial suppression of scarring
led to irreversibly impaired regeneration. We concluded that
TGF/Activin-dependent collagen deposition in the subacute phase
is essential for subsequent regenerative success.
Alk5/4-i treatment does not promote degradation
of pre-existing collagen
Collagen fibers are known to undergo continuous turnover in the
healing infarcts (Bowers et al., 2010; Chen and Frangogiannis,
2010). Thus, the stimulatory role of TGF for collagen
accumulation might occur by either enhancing collagen production
and/or decreasing its degradation. To distinguish between these
possibilities, we designed an experiment in which the drug
treatment was applied after scar formation. For this purpose, the
animals were kept in normal conditions for 14 days after cryoinjury
to allow collagen deposition. After this time, the fish were
transferred to water with Alk5/4-i for the next 14 days, and the
amount of scarring was assessed. Histological analysis revealed
advanced regeneration with only residual collagen fibers within the
post-infarcts of the control hearts (Fig. 5B). By contrast, abundant
scar material and regenerative failure were observed after the drug
shift (among seven fish, five hearts displayed enhanced scarring
without infarct bulging, and two hearts regenerated myocardium
with residual scarring comparable to the control; Fig. 5D). The
presence of the persisting collagen fibers suggests that the
inhibition of Alk5/4 receptors did not enhance degradation of the
pre-existing collagenous matrix. We concluded that TGF/Activin
signaling controls collagen accumulation predominantly by
stimulating its synthesis. Moreover, we found no deformation of
infarct geometry, indicating a mechanical role of collagen as
supporting material in the damaged tissue of the injured heart.
Exposure to Alk5/4-i suppresses the function of
fibroblast-like cells in ECM synthesis
The main components of the cardiac ECM include structural
proteins such as collagen, adhesive proteins such as fibronectins,
and de-adhesive tissue remodeling proteins such as tenascins
(Bowers et al., 2010; Corda et al., 2000). We set out to
systematically determine the effect of TGF/Activin signaling on
the expression of these ECM components during the regenerative
phase at 14 dpci, when the fibrotic tissue is abundantly detected in
the post-infarct. Consistent with our previous observations (Fig.
3G), the accumulation of collagen matrix was strongly impaired in
the post-infarcts of Alk5/4-i-treated animals as compared with the
controls (Fig. 6A,E,I,L). Moreover, Alk5/4-i treatment resulted in
the reduction of Fibronectin, a broadly expressed core matrix
component that provides a framework for cell adhesion (Fig.
6C,G). Notably, the tissue remodeling protein Tenascin C
(Imanaka-Yoshida et al., 2004), which is normally induced at the
infarct-myocardium interface, was completely suppressed after
antagonizing Alk5/4 receptors (Fig. 6K,N). Taken together, the
deposition of crucial ECM components in the post-infarct zone,
including structural, adhesive and de-adhesive proteins, requires
TGF/Activin signaling.
The source of the ECM in mammalian myocardial infarcts is
fibroblasts, myofibroblasts and smooth muscle cells (Camelliti et
al., 2005; Dobaczewski et al., 2010b; Porter and Turner, 2009). We
aimed to determine whether TGF/Activin signaling regulates the
ECM content by acting on the recruitment/differentiation of these
ECM-producing cells. To visualize the fibroblasts of the infarct we
used antibodies against Vimentin, a cytoplasmic intermediate
filament-associated protein. The post-infarct of control and Alk5/4-
i-treated fish displayed a dense network of Vimentin-positive cells,
which was even augmented in the hearts treated with Alk5/4-i (Fig.
6K,N). This accumulation of fibroblasts might represent a
compensatory reaction to their reduced activity in the deposition of
ECM proteins. To identify myofibroblasts and smooth muscle cells,
we used antibodies against -SMA, a marker of their specific
contractile microfilamentous apparatus. In control regenerating
hearts, -SMA specifically labeled the outer border of the post-
infarct (Fig. 6D). A similar peripheral rim of -SMA-positive cells
persisted in hearts treated with Alk5/4-i (Fig. 6H). This
demonstrates that the inhibition of TGF/Activin signaling did not
impair the accumulation of Vimentin-positive and -SMA-positive
cells of the fibrotic tissue. Taken together, despite the presence of
ECM-producing cells, the synthesis of various ECM components
Fig. 5. Transient scar formation is an
essential reparative step toward heart
regeneration. AFOG staining of zebrafish
hearts at 28 dpci after a transient drug
treatment during the initial 14 days (A,C) or the
final 14 days (B,D) of the experiment.
(A,B)Control (DMSO-treated) hearts display
normal regeneration. Only a small area contains
collagen fibers (arrow). (C)Inhibition of Alk5/4
during the initial phase of scar formation is
deleterious, resulting in a complete lack of
regeneration. Despite the subsequent 14 days of
normal conditions, the post-infarct developed
an inflated infarct phenotype. (D)Inhibition of
Alk5/4 starting at 14 dpci, after the time needed
for scar deposition, does not cause architectural
deformations of the post-infarct. The injury site
contains collagen, but scar replacement with
cardiac tissue appears to be impaired in
comparison to control (B). Scale bar: 300m.
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was markedly affected by exposure to Alk5/4-i. We concluded that
disruption of TGF/Activin signaling results in functionally
defective fibroblast-like cells that exhibit impaired ECM
deposition.
Epicardial and endocardial cells are important components in
heart regeneration in zebrafish (Kikuchi et al., 2011a; Kikuchi et
al., 2011b). They induce expression of the RA-synthesizing
enzyme Raldh2 (Aldh1a2 – Zebrafish Information Network) to
increase production of RA, a cardiogenesis-stimulating factor. To
test the role of TGF/Activin signaling in the epicardium and the
endocardium after myocardial infarction, we immunoassayed
Raldh2 in control and Alk5/4-i-treated animals. In uninjured
animals, Raldh2 specifically labeled the epicardium
(supplementary material Fig. S9). At 14 dpci, Raldh2-positive
epicardial cells invaded the injury area and surrounded the
damaged myocardium. Consistent with previous studies (Kikuchi
et al., 2011b), the expression of Raldh2 was induced in a subset of
endocardial cells within the intact myocardium. In comparison with
the control animals, inhibition of TGF/Activin signaling did not
affect the distribution of Raldh2-positive epicardial and endocardial
cells (supplementary material Fig. S9B,C). This suggests that the
lack of cardiac regeneration in Alk5/4-i-treated fish is not caused
by the defective injury responses of epicardium and endocardium.
Inhibition of TGF/Activin signaling attenuates
cardiomyocyte proliferation
The reparative and regenerative phases of heart regeneration are
overlapping, as the deposition of scar tissue is concomitant with the
enhanced cell cycle re-entry of cardiomyocytes, which will lead to
restoration of the functional cardiac tissue (Chablais et al., 2011).
Consistently, closer examination of the control hearts at 14 dpci
revealed spreading of myocytes along the border with fibrotic
tissue (Fig. 2A and Fig. 6K). Inhibition of TGF signaling
impaired this shift of cardiomyocytes into the damaged tissue (Fig.
2B and Fig. 6N). Notably, the impaired invasion of the
myocardium was associated with the suppression of Tenascin C,
which is a cell migration-promoting factor at the infarct-
myocardium boundary (Imanaka-Yoshida et al., 2004). This
observation suggests that TGF/Activin signaling is required for
the invasion of a new myocardium into the injury area.
To examine the mitogenic role of TGF/Activin in regenerating
hearts, we assessed cell proliferation with antibodies against Mcm5
(a DNA replication licensing factor) at 14 dpci. To identify nuclei of
cardiomyocytes, we used a transgenic strain that expresses nuclear
DsRed2 under the control of the cmlc2 promoter (cmlc2::DsRed2-
Nuc). In control heart sections with a representative myocardial
injury, the proportion of Mcm5-positive cardiomyocytes was 8.6%
(Fig. 7A,B). Treatment with Alk5/4-i resulted in a 50% reduction in
the number of proliferating cardiomyocytes (Fig. 7B,C). Non-cardiac
cell proliferation (Mcm5-positive and DsRed2-negative cells), by
contrast, was enhanced by the Alk5/4-i treatment by ~30% (Fig. 7D).
This result is consistent with our previous observation of augmented
Vimentin-positive tissue in the injury area (Fig. 6K,N). We
concluded that the mitogenic role of TGF/Activin signaling is tissue
dependent: it has a stimulating effect on cardiomyocytes but not on
the other cell types of the post-infarct.
The reduced proliferation of myocytes in Alk5/4-i-treated fish
can be explained either by the primary requirement of
TGF/Activin signaling as a mitogenic factor or as the secondary
consequence of impaired cell migration and tissue remodeling at
the myocardial-infarct boundary. To distinguish between these
possibilities, we designed another drug-shift experiment to
Fig. 6. Inhibition of Alk5/4 impairs the production of
ECM proteins in the post-infarct. Analyses of heart
sections from transgenic fish expressing nuclear DsRed2-
Nuc under the cmlc2 cardiomyocyte-specific promoter at
14 dpci. Dashed lines represent the injured areas. DsRed2-
Nuc is in red (C,D,G,H) or blue (J-K,M-N). (A-D,I-K)
Adjacent sections of control hearts. (E-H,L-N) Adjacent
sections of Alk5/4-i-treated hearts. (A,I)AFOG staining
visualizes abundant collagen fibers (blue) at the injury site
of control hearts. (E,L)Inhibition of TGF/Activin signaling
blocks collagen deposition. (B,F)The injury site is
demarcated by the absence of Tropomyosin protein (blue).
The post-infarct is larger in hearts treated with the drug (F)
than in control (B). DAPI (yellow) labels all nuclei.
(C,G)Exposure to Alk5/4-i (G) attenuates Fibronectin
production (green) in comparison to control (C). (D,H)-
smooth muscle actin-positive cells (SMA, green) equally
surround the post-infarct border in control and drug-
treated hearts. (J,M)The injury site is demarcated by the
absence of cmlc2::DsRed2-Nuc (blue). DAPI (yellow) labels
all nuclei. (K,K,N,N) The contra-adhesive matrix protein
Tenascin C (TNC, red) is predominantly upregulated at the
infarct-myocardium interface in control hearts (K,K).
Treatment with Alk5/4-i completely abolished Tenascin C
expression, but increased Vimentin-positive tissue (green;
N,N). (K,N) Higher magnifications of the boxed areas in
K,N. Arrow (K) indicates the invasion of new myocardium.
Scale bars: 300m.
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determine the immediate effects caused by short-term inhibition of
Alk5/4 receptors during normally progressing regeneration (Fig.
7E). Transgenic fish after myocardial infarction were first allowed
to initiate scar deposition and cardiomyocyte proliferation under
normal conditions for the first 7 days, and were then kept in the
presence of Alk5/4-i for only 3 days. To identify DNA-replicating
cells, the fish were in addition exposed to BrdU for the last 24
hours of the experiment, and cell proliferation was assessed. In
sections with scar tissue of control hearts, BrdU labeled ~4% of the
cardiomyocytes, which were predominantly located in the vicinity
of the injury (Fig. 7F,H). A short-term exposure to Alk5/4-i resulted
in a ~70% reduction of BrdU-positive cardiomyocytes (Fig. 7G,H).
The rapid reduction of BrdU incorporation suggests that
TGF/Activin is directly or indirectly required to maintain the
proliferative capacity of cardiomyocytes.
To further test the stimulatory role of TGF/Activin in cardiac
regeneration, we used another injury method that is based on partial
amputation of the ventricular apex (Poss et al., 2002). The design
of the experiment was the same as that described above, in which
the fish after ventricular resection were allowed to initiate
regeneration for 7 days under normal conditions, followed by 3
days of Alk5/4-i treatment including BrdU treatment for the final
day (supplementary material Figs S10, S11). The pulse exposure to
the inhibitor significantly reduced cardiomyocyte proliferation.
This demonstrates that the mitogenic role of TGF/Activin for
cardiomyocytes is independent of the type of heart injury.
DISCUSSION
Heart regeneration following cryoinjury-induced myocardial
infarction is remarkably efficient in adult zebrafish (Chablais et al.,
2011; Gonzalez-Rosa et al., 2011; Schnabel et al., 2011). The
present study identifies the requirement of TGF/Activin signaling
to coordinate the sequence of diverse cellular events during this
process. Our data support a model in which zebrafish heart
regeneration can be subdivided into three overlapping phases (Fig.
8). First, myocardial cell death triggers an inflammatory response
that is characterized by the infiltration of the infarct with activated
leukocytes and fibroblast-like cells, which express TGF ligands
(Fig. 8A). Second, as the wound becomes cleared of dead cells and
matrix debris, the reparative phase begins at ~4 dpci (Fig. 8B).
TGF/Activin signaling stimulates the recruited fibroblast-like cells
to synthesize the collagen-rich ECM. Third, at the onset of scar
formation at 7 dpci, the regenerative phase begins (Fig. 8C). While
the fibrotic tissue is still maturing, TGF/Activin signaling
promotes proliferation of cardiomyocytes located in the vicinity of
the post-infarct. Tissue remodeling and invasion of new cardiac
muscle to replace scar tissue are associated with the TGF-
dependent expression of Tenascin C, an extracellular protein with
contra-adhesive properties. Thus, the regenerative phase is
characterized by two opposing processes: scar deposition in the
damaged area and scar degradation at the position where new
cardiomyocytes invade the post-infarct. It is not known how a
balance between both cellular events is achieved. Here, we show
Fig. 7. TGF/Activin signaling promotes cardiomyocyte
proliferation during heart regeneration. 
(A,A,C,C) Heart sections of transgenic cmlc2::DsRed2-Nuc
(red) fish immunostained for Tropomyosin (blue) and Mcm5
(green) to detect mitotic cells at 14 dpci. DAPI (yellow in the
left panels) marks nuclei. Proliferating cardiomyocytes are
identified by co-expression of DsRed2 and Mcm5. The post-
infarcts are encircled by dashed lines. (A,C) Higher
magnifications of the boxed areas in A,C. (A,A) In control
hearts, proliferating cardiomyocytes are located in the vicinity
of the injury site. Non-cardiac Mcm5-positive cells are
distributed predominantly at the post-infarct wall. Arrow (A)
indicates the invasion of new myocardium. (C,C) Exposure
to Alk5/4-i attenuates cardiomyocyte proliferation and
expansion. (B)The ratio of Mcm5-positive DsRed2-positive
nuclei to all DsRed2-positive nuclei demonstrates a reduction
of proliferating cardiomyocytes after drug treatment (n10).
(D)The ratio of Mcm5-positive to DAPI-positive nuclei shows
enhanced proliferation of non-cardiac cells after drug
treatment (n10). (E)Experimental design to demonstrate the
immediate effect of Alk5/4-i on cardiomyocyte proliferation.
(F-G) Confocal images of hearts from cmlc::DsRed2-Nuc
(red) transgenic fish. Tropomyosin (blue), DAPI (yellow), BrdU
(green). Proliferating cardiomyocytes are identified by the co-
expression of DsRed2 and BrdU. Dashed lines indicate the
post-infarct. (F,G) Higher magnifications of the boxed areas
in F,G. (H)The ratio of BrdU-positive DsRed2-positive nuclei
to all DsRed2-positive nuclei. BrdU incorporation in
cardiomyocytes was significantly decreased after Alk5/4-i
exposure. Error bars indicate s.e.m.; n=10; *P<0.05, t-test.
Scale bars: 300m.
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that the equilibrium between the reparative and regenerative
responses is coordinated by the TGF/Activin signaling pathway.
The inhibition of this signaling impairs both collagenous scar
formation and cardiomyocyte propagation.
The injury response of the nonregenerative mammalian heart is
also described in three phases – inflammation, granulation tissue
proliferation and scar maturation – all of which are regulated by
multifunctional TGF signaling (Dobaczewski et al., 2010b).
Although the initial two phases are similar between zebrafish and
mammals, in zebrafish the collagenous matrix does not ultimately
develop a mature scar but instead undergoes remodeling and is
replaced with a new myocardium (Chablais et al., 2011; Gonzalez-
Rosa et al., 2011; Schnabel et al., 2011). Thus, the unique feature of
the regenerating zebrafish heart is a switch from the deposition to the
degradation of fibrotic tissue to allow for the expansion of the new
myocardium. Studies in rodents demonstrate that the modulation of
TGF signaling using pharmacological approaches or gene/protein
therapies can reduce fibrosis and deleterious ventricular remodeling
(Alegria et al., 2005; Kuwahara et al., 2002; Okada et al., 2005; Tan
et al., 2010). Finding the optimal time window for antagonizing
TGF signaling after myocardial infarction is essential in order to
precisely target the pathological processes that occur during the
specific phase of heart repair (Leask, 2010).
Downregulation of TGF/Activin signaling caused a wide range
of cellular phenotypes affecting heart regeneration in zebrafish.
Specifically, we identified the following processes to be affected
after Alk5/4-i treatment: (1) suppressed collagen accumulation; (2)
attenuated Fibronectin deposition; (3) blocked Tenascin C
expression at the interface between myocardium and fibroblasts;
(4) stimulated fibroblast proliferation; (5) attenuated cardiomyocyte
proliferation; and (6) impairment of cardiomyocyte spreading into
the post-infarct. These diverse effects demonstrate that
TGF/Activin signaling can be considered as a molecular link
between different responses exerted by various cell subpopulations
in the regenerating heart. The comparison between mammalian and
zebrafish hearts reveals a common effect on fibroblasts to stimulate
their proliferation and ECM protein deposition (Leask, 2007;
Dobaczewski et al., 2010a). The most notable difference occurs at
the level of the cardiomyocyte response. In mammals, TGF
promotes pathologic cardiomyocyte hypertrophy (Rosenkranz,
2004), as opposed to the healthy myocyte proliferation observed in
zebrafish. These diverse outcomes might be due to either
differential intrinsic cardiomyocyte properties or additional
environmental factors. Elucidation of these underlying mechanisms
will be crucial to understand the differences in regenerative
capacities among vertebrates.
One of the important findings of the present study is that the
initial transient scar deposition is beneficial for heart regeneration
in zebrafish. This discovery is paradoxical to the prevalent concept
of ‘scarless regeneration’ in mammalian fetal wound healing, limb
regeneration in newts and fin regeneration in teleost fish (Brockes
and Kumar, 2008; Palatinus et al., 2010; Poss, 2010). Indeed, in the
case of the skin and appendages, the regenerative process can be
achieved directly after wound healing without going through a
reparative phase of scar formation. We found that such a shortcut
is deleterious for the heart as a force-generating contractile organ.
Insufficient collagen deposition after Alk5/4 inhibition coincided
with the alteration of infarct shape, which was characterized by
bulging tissue beyond the ventricular circumference. It is
conceivable that a lack of collagen, which normally provides tissue
stiffness, affects robustness of the damaged ventricular wall that is
challenged to withstand the internal blood pressure (Holmes et al.,
Fig. 8. TGF/Activin signaling coordinates the reparative and regenerative phases in response to myocardial infarction.
(A)Inflammatory phase. In the acute stage after cryoinjury (0-4 dpci), massive death of cardiomyocytes triggers an inflammatory response
associated with immune cell infiltration. This response leads to clearance of damaged tissue. (B)The reparative phase. During the subacute stage of
myocardial infarction (4-7 dpci), non-cardiac cells accumulate at the injury site. TGF ligands are transcriptionally induced in the post-infarct.
Smad3-mediated TGF signaling stimulates infarct healing by enhancing ECM deposition. (C)The regenerative phase (7-60 dpci). TGF/Activin
signaling continues its profibrotic action in the post-infarct, but it also promotes cardiomyocyte proliferation and invasion. The new myocardium
progressively replaces the fibrotic tissue, resulting in resolution of the scar and complete cardiac regeneration.
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2005). Because the wall tension is proportional to the cavity
diameter and inversely proportional to the wall thickness (Laplace’s
law) (Yin, 1981), the increased ventricular wall stress of the
collagen-deficient infarct can lead to biomechanical deformations
resulting in an augmented curvature of the infarct. From this
physical law, we surmise that transient scar formation is an
essential step to maintain ventricular wall stiffness during the
subacute regenerative stage. This raises the idea of potential
advantages of having a transient scar that can progressively be
replaced by new invading functional tissue.
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